Gelonghui November 23丨Melander (688273.SH) Investor Relations Activity Record Form shows that according to the company's investment and plans for new products, it is expected that in the next 1-2 years, the reproductive anti-aging product line and sports rehabilitation product line will continue to grow by 50%-100%.
麦澜德(688273.SH)：预计未来1-2年生殖抗衰产品线和运动康复产品线仍将保持50%-100%的增长
Melander (688273.SH): It is expected that the reproductive anti-aging product line and exercise rehabilitation product line will maintain 50%-100% growth in the next 1-2 years
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.